Multiplex targeted proteomic assay for biomarker detection in plasma: A pancreatic cancer biomarker case study

Journal of Proteome Research

Volumn 11, Issue 3, 2012, Pages 1937-1948

  Pan, Sheng ^a   Chen, Ru ^a   Brand, Randall E ^b   Hawley, Sarah ^c   Tamura, Yasuko ^a   Gafken, Philip R ^d   Milless, Brian P ^d   Goodlett, David R ^a   Rush, John ^e   Brentnall, Teresa A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c Canary Foundation   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e CELL SIGNALING TECHNOLOGY   (United States)

Author keywords

biomarker; chronic pancreatitis; mass spectrometer; multiple reaction monitoring (MRM); pancreas; pancreatic cancer; pancreatic ductal adenocarcinoma; plasma; selected reaction monitoring (SRM); targeted proteomics

Indexed keywords

GELSOLIN; LUMICAN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; STRATIFIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

BLOOD ANALYSIS; CANCER DIAGNOSIS; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE MARKER; HUMAN; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEOMICS;

14-3-3 PROTEINS; AMINO ACID SEQUENCE; AREA UNDER CURVE; CARCINOMA, PANCREATIC DUCTAL; CASE-CONTROL STUDIES; CHONDROITIN SULFATE PROTEOGLYCANS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXONUCLEASES; GELSOLIN; HUMANS; KERATAN SULFATE; MOLECULAR SEQUENCE DATA; PANCREATIC NEOPLASMS; PEPTIDE FRAGMENTS; PEPTIDE MAPPING; PILOT PROJECTS; PROTEOMICS; ROC CURVE; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TUMOR MARKERS, BIOLOGICAL;

EID: 84857847927     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr201117w     Document Type: Conference Paper

References (39)

1. Jemal, A.; Siegel, R.; Ward, E.; Murray, T.; Xu, J.; Smigal, C.; Thun, M. J. Cancer statistics, 2006 CA Cancer J. Clin. 2006, 56, 106-30
2. Brand, R. The diagnosis of pancreatic cancer Cancer J. 2001, 7, 287-97
3. Grote, T.; Logsdon, C. D. Progress on molecular markers of pancreatic cancer Curr. Opin. Gastroenterol. 2007, 23, 508-14
4. Harsha, H. C.; Kandasamy, K.; Ranganathan, P.; Rani, S.; Ramabadran, S.; Gollapudi, S.; Balakrishnan, L.; Dwivedi, S. B.; Telikicherla, D.; Selvan, L. D.; Goel, R.; Mathivanan, S.; Marimuthu, A.; Kashyap, M.; Vizza, R. F.; Mayer, R. J.; Decaprio, J. A.; Srivastava, S.; Hanash, S. M.; Hruban, R. H.; Pandey, A. A compendium of potential biomarkers of pancreatic cancer PLoS Med. 2009, 6, e1000046
5. Ranganathan, P.; Harsha, H. C.; Pandey, A. Molecular alterations in exocrine neoplasms of the pancreas Arch. Pathol. Lab. Med. 2009, 133, 405-12
6. Brand, R. E.; Nolen, B. M.; Zeh, H. J.; Allen, P. J.; Eloubeidi, M. A.; Goldberg, M.; Elton, E.; Arnoletti, J. P.; Christein, J. D.; Vickers, S. M.; Langmead, C. J.; Landsittel, D. P.; Whitcomb, D. C.; Grizzle, W. E.; Lokshin, A. E. Serum biomarker panels for the detection of pancreatic cancer Clin. Cancer Res. 2011, 17, 805-16
7. Faca, V. M.; Song, K. S.; Wang, H.; Zhang, Q.; Krasnoselsky, A. L.; Newcomb, L. F.; Plentz, R. R.; Gurumurthy, S.; Redston, M. S.; Pitteri, S. J.; Pereira-Faca, S. R.; Ireton, R. C.; Katayama, H.; Glukhova, V.; Phanstiel, D.; Brenner, D. E.; Anderson, M. A.; Misek, D.; Scholler, N.; Urban, N. D.; Barnett, M. J.; Edelstein, C.; Goodman, G. E.; Thornquist, M. D.; McIntosh, M. W.; DePinho, R. A.; Bardeesy, N.; Hanash, S. M. A mouse to human search for plasma proteome changes associated with pancreatic tumor development PLoS Med. 2008, 5, e123
8. Pan, S.; Chen, R.; Crispin, D. A.; May, D.; Stevens, T.; McIntosh, M. W.; Bronner, M. P.; Ziogas, A.; Anton-Culver, H.; Brentnall, T. A. Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling J. Proteome Res. 2011, 10, 2359-76
9. Surinova, S.; Schiess, R.; Huttenhain, R.; Cerciello, F.; Wollscheid, B.; Aebersold, R. On the development of plasma protein biomarkers J. Proteome Res. 2011, 10, 5-16
10. Kitteringham, N. R.; Jenkins, R. E.; Lane, C. S.; Elliott, V. L.; Park, B. K. Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2009, 877, 1229-39
11. Pan, S.; Aebersold, R.; Chen, R.; Rush, J.; Goodlett, D. R.; McIntosh, M. W.; Zhang, J.; Brentnall, T. A. Mass spectrometry based targeted protein quantification: methods and applications J. Proteome Res. 2009, 8, 787-97
12. Schiess, R.; Wollscheid, B.; Aebersold, R. Targeted proteomic strategy for clinical biomarker discovery Mol. Oncol. 2009, 3, 33-44
13. Ye, X.; Blonder, J.; Veenstra, T. D. Targeted proteomics for validation of biomarkers in clinical samples Brief. Funct. Genomics Proteomics 2009, 8, 126-35
14. Anderson, N. L.; Anderson, N. G.; Haines, L. R.; Hardie, D. B.; Olafson, R. W.; Pearson, T. W. Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA) J. Proteome Res. 2004, 3, 235-44
15. Keshishian, H.; Addona, T.; Burgess, M.; Kuhn, E.; Carr, S. A. Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution Mol. Cell. Proteomics 2007, 6, 2212-29
16. Kettenbach, A. N.; Rush, J.; Gerber, S. A. Absolute quantification of protein and post-translational modification abundance with stable isotope-labeled synthetic peptides Nat. Protoc. 2011, 6, 175-86
17. Stahl-Zeng, J.; Lange, V.; Ossola, R.; Eckhardt, K.; Krek, W.; Aebersold, R.; Domon, B. High sensitivity detection of plasma proteins by multiple reaction monitoring of N-glycosites Mol. Cell. Proteomics 2007, 6, 1809-17
18. Whiteaker, J. R.; Lin, C.; Kennedy, J.; Hou, L.; Trute, M.; Sokal, I.; Yan, P.; Schoenherr, R. M.; Zhao, L.; Voytovich, U. J.; Kelly-Spratt, K. S.; Krasnoselsky, A.; Gafken, P. R.; Hogan, J. M.; Jones, L. A.; Wang, P.; Amon, L.; Chodosh, L. A.; Nelson, P. S.; McIntosh, M. W.; Kemp, C. J.; Paulovich, A. G. A targeted proteomics-based pipeline for verification of biomarkers in plasma Nat. Biotechnol. 2011, 29, 625-34
19. Chen, R.; Yi, E. C.; Donohoe, D.; Pan, S.; Eng, J.; Crispin, D. A.; Lane, Z.; Goodlett, D. A.; Bronner, M. P.; Aebersold, R.; Brentnall, T. A. Pancreatic cancer proteome: the proteins that underlie invasion, metastasis, and immunologic escape Gastroenterology 2005, 129, 1187-97
20. Gronborg, M.; Kristiansen, T. Z.; Iwahori, A.; Chang, R.; Reddy, R.; Sato, N.; Molina, H.; Jensen, O. N.; Hruban, R. H.; Goggins, M. G.; Maitra, A.; Pandey, A. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach Mol. Cell. Proteomics 2006, 5, 157-71
21. Pan, S.; Chen, R.; Reimel, B. A.; Crispin, D. A.; Mirzaei, H.; Cooke, K.; Coleman, J. F.; Lane, Z.; Bronner, M. P.; Goodlett, D. R.; McIntosh, M. W.; Traverso, W.; Aebersold, R.; Brentnall, T. A. Quantitative proteomics investigation of pancreatic intraepithelial neoplasia Electrophoresis 2009, 30, 1132-44
22. Stevens, T.; Dumot, J. A.; Parsi, M. A.; Zuccaro, G.; Vargo, J. J. Combined endoscopic ultrasound and secretin endoscopic pancreatic function test in patients evaluated for chronic pancreatitis Dig. Dis. Sci. 2010, 55, 2681-87
23. MacLean, B.; Tomazela, D. M.; Shulman, N.; Chambers, M.; Finney, G. L.; Frewen, B.; Kern, R.; Tabb, D. L.; Liebler, D. C.; MacCoss, M. J. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments Bioinformatics 2010, 26, 966-68
24. McIntosh, M. W.; Drescher, C.; Karlan, B.; Scholler, N.; Urban, N.; Hellstrom, K. E.; Hellstrom, I. Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma Gynecol. Oncol. 2004, 95, 9-15
25. Pepe, M. S.; Longton, G. Standardizing diagnostic markers to evaluate and compare their performance Epidemiology 2005, 16, 598-603
26. Pepe, M. S. The Statistical Evaluation of Medical Tests for Classification and Prediction; Oxford University Press: Oxford, U.K., 2003.
27. Palmer, C.; Duan, X.; Hawley, S.; Scholler, N.; Thorpe, J. D.; Sahota, R. A.; Wong, M. Q.; Wray, A.; Bergan, L. A.; Drescher, C. W.; McIntosh, M. W.; Brown, P. O.; Nelson, B. H.; Urban, N. Systematic evaluation of candidate blood markers for detecting ovarian cancer PLoS One 2008, 3, e2633
28. Reiter, L.; Rinner, O.; Picotti, P.; Huttenhain, R.; Beck, M.; Brusniak, M. Y.; Hengartner, M. O.; Aebersold, R. mProphet: automated data processing and statistical validation for large-scale SRM experiments Nat. Methods 2011, 8, 430-35
29. Deutsch, E. W.; Lam, H.; Aebersold, R. PeptideAtlas: a resource for target selection for emerging targeted proteomics workflows EMBO Rep. 2008, 9, 429-34
30. Mathivanan, S.; Ahmed, M.; Ahn, N. G.; Alexandre, H.; Amanchy, R.; Andrews, P. C.; Bader, J. S.; Balgley, B. M.; Bantscheff, M.; Bennett, K. L.; Bjorling, E.; Blagoev, B.; Bose, R.; Brahmachari, S. K.; Burlingame, A. S.; Bustelo, X. R.; Cagney, G.; Cantin, G. T.; Cardasis, H. L.; Celis, J. E.; Chaerkady, R.; Chu, F.; Cole, P. A.; Costello, C. E.; Cotter, R. J.; Crockett, D.; DeLany, J. P.; De Marzo, A. M.; DeSouza, L. V.; Deutsch, E. W.; Dransfield, E.; Drewes, G.; Droit, A.; Dunn, M. J.; Elenitoba-Johnson, K.; Ewing, R. M.; Van Eyk, J.; Faca, V.; Falkner, J.; Fang, X.; Fenselau, C.; Figeys, D.; Gagne, P.; Gelfi, C.; Gevaert, K.; Gimble, J. M.; Gnad, F.; Goel, R.; Gromov, P.; Hanash, S. M.; Hancock, W. S.; Harsha, H. C.; Hart, G.; Hays, F.; He, F.; Hebbar, P.; Helsens, K.; Hermeking, H.; Hide, W.; Hjerno, K.; Hochstrasser, D. F.; Hofmann, O.; Horn, D. M.; Hruban, R. H.; Ibarrola, N.; James, P.; Jensen, O. N.; Jensen, P. H.; Jung, P.; Kandasamy, K.; Kheterpal, I.; Kikuno, R. F.; Korf, U.; Korner, R.; Kuster, B.; Kwon, M. S.; Lee, H. J.; Lee, Y. J.; Lefevre, M.; Lehvaslaiho, M.; Lescuyer, P.; Levander, F.; Lim, M. S.; Lobke, C.; Loo, J. A.; Mann, M.; Martens, L.; Martinez-Heredia, J.; McComb, M.; McRedmond, J.; Mehrle, A.; Menon, R.; Miller, C. A.; Mischak, H.; Mohan, S. S.; Mohmood, R.; Molina, H.; Moran, M. F.; Morgan, J. D.; Moritz, R.; Morzel, M.; Muddiman, D. C.; Nalli, A.; Navarro, J. D.; Neubert, T. A.; Ohara, O.; Oliva, R.; Omenn, G. S.; Oyama, M.; Paik, Y. K.; Pennington, K.; Pepperkok, R.; Periaswamy, B.; Petricoin, E. F.; Poirier, G. G.; Prasad, T. S.; Purvine, S. O.; Rahiman, B. A.; Ramachandran, P.; Ramachandra, Y. L.; Rice, R. H.; Rick, J.; Ronnholm, R. H.; Salonen, J.; Sanchez, J. C.; Sayd, T.; Seshi, B.; Shankari, K.; Sheng, S. J.; Shetty, V.; Shivakumar, K.; Simpson, R. J.; Sirdeshmukh, R.; Siu, K. W.; Smith, J. C.; Smith, R. D.; States, D. J.; Sugano, S.; Sullivan, M.; Superti-Furga, G.; Takatalo, M.; Thongboonkerd, V.; Trinidad, J. C.; Uhlen, M.; Vandekerckhove, J.; Vasilescu, J.; Veenstra, T. D.; Vidal-Taboada, J. M.; Vihinen, M.; Wait, R.; Wang, X.; Wiemann, S.; Wu, B.; Xu, T.; Yates, J. R.; Zhong, J.; Zhou, M.; Zhu, Y.; Zurbig, P.; Pandey, A. Human Proteinpedia enables sharing of human protein data Nat. Biotechnol. 2008, 26, 164-67
31. Jones, P.; Cote, R. G.; Martens, L.; Quinn, A. F.; Taylor, C. F.; Derache, W.; Hermjakob, H.; Apweiler, R. PRIDE: a public repository of protein and peptide identifications for the proteomics community Nucleic Acids Res. 2006, 34, D659-D663
32. Addona, T. A.; Abbatiello, S. E.; Schilling, B.; Skates, S. J.; Mani, D. R.; Bunk, D. M.; Spiegelman, C. H.; Zimmerman, L. J.; Ham, A. J.; Keshishian, H.; Hall, S. C.; Allen, S.; Blackman, R. K.; Borchers, C. H.; Buck, C.; Cardasis, H. L.; Cusack, M. P.; Dodder, N. G.; Gibson, B. W.; Held, J. M.; Hiltke, T.; Jackson, A.; Johansen, E. B.; Kinsinger, C. R.; Li, J.; Mesri, M.; Neubert, T. A.; Niles, R. K.; Pulsipher, T. C.; Ransohoff, D.; Rodriguez, H.; Rudnick, P. A.; Smith, D.; Tabb, D. L.; Tegeler, T. J.; Variyath, A. M.; Vega-Montoto, L. J.; Wahlander, A.; Waldemarson, S.; Wang, M.; Whiteaker, J. R.; Zhao, L.; Anderson, N. L.; Fisher, S. J.; Liebler, D. C.; Paulovich, A. G.; Regnier, F. E.; Tempst, P.; Carr, S. A. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma Nat. Biotechnol. 2009, 27, 633-41
33. Omenn, G. S. THE HUPO Human Plasma Proteome Project Proteomics Clin. Appl. 2007, 1, 769-79
34. Chen, R.; Brentnall, T. A.; Pan, S.; Cooke, K.; Moyes, K. W.; Lane, Z.; Crispin, D. A.; Goodlett, D. R.; Aebersold, R.; Bronner, M. P. Quantitative proteomics analysis reveals that proteins differentially expressed in chronic pancreatitis are also frequently involved in pancreatic cancer Mol. Cell. Proteomics 2007, 6, 1331-42
35. Lowenfels, A. B.; Maisonneuve, P.; Cavallini, G.; Ammann, R. W.; Lankisch, P. G.; Andersen, J. R.; Dimagno, E. P.; Andren-Sandberg, A.; Domellof, L. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group N. Engl. J. Med. 1993, 328, 1433-37
36. Malka, D.; Hammel, P.; Maire, F.; Rufat, P.; Madeira, I.; Pessione, F.; Levy, P.; Ruszniewski, P. Risk of pancreatic adenocarcinoma in chronic pancreatitis Gut 2002, 51, 849-52
37. Chen, R.; Crispin, D. A.; Pan, S.; Hawley, S.; McIntosh, M. W.; May, D.; Anton-Culver, H.; Ziogas, A.; Bronner, M. P.; Brentnall, T. A. Pilot study of blood biomarker candidates for detection of pancreatic cancer Pancreas 2010, 39, 981-88
38. Sandblom, G.; Granroth, S.; Rasmussen, I. C. TPS, CA 19-9, VEGF-A, and CEA as diagnostic and prognostic factors in patients with mass lesions in the pancreatic head Ups. J. Med. Sci. 2008, 113, 57-64
39. Anderson, L.; Hunter, C. L. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins Mol. Cell. Proteomics 2006, 5, 573-88